Back to CVE records
Medium 4.8Published Oct 23, 2026

CVE-2026-4950Stored Cross-Site Scripting in CustomerAdministration Portal (KundenManager) in VertiGIS WebOrderSystem

Updated under an hour ago ()

Does this affect you?

It affects VertiGIS Ltd. WebOrderSystem (KundenManager). Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

The CustomerAdministration portal (KundenManager) of VertiGIS WebOrderSystem allows privileged users to manage the employees of defined companies (user groups). User properties, for example the "secondName" parameter, can be filled with JavaScript code while editing a user. The code is stored and executed in the browser of any other privileged user who opens the edited user entry or the user overview of the corresponding user group. An authenticated attacker with access to the portal can use this to run script code in the session of other portal users. Version 7.0.8.6, the latest available at the time of testing, is affected. The vendor did not provide information about further affected versions.

CVSS
4.8 MEDIUM (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N
Weakness (CWE)
CWE-79
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
SEC-VLab
NVD analysis
Deferred
Record last updated
Oct 23, 2026
First seen by InfoSec Signals
Oct 23, 2026

Affected products

Affected products
VertiGIS Ltd. WebOrderSystem (KundenManager)
vertigis:webordersystem_kundenmanager (from the name)
through 7.0.8.6
CNA record

References

  • third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.